Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review. | JAMA Dermatol | 2022 | 35044423 | PubTator, text mining | PubMed |
| Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives. | Biol Rev Camb Philos Soc | 2022 | 35043558 | PubTator, text mining | PubMed |
| Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma. | Mol Biomed | 2022 | 35031886 | PubTator, text mining | PubMed |
| Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis. | Infect Drug Resist | 2022 | 35023934 | PubTator, text mining | PubMed |
| Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis. | Thorax | 2022 | 35017314 | PubTator, text mining | PubMed |
| Defensin-lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics. | Biochem Soc Trans | 2022 | 35015081 | PubTator, text mining | PubMed |
| Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms. | Int J Mol Sci | 2022 | 35008974 | PubTator, text mining | PubMed |
| A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes. | J Med Chem | 2022 | 35007061 | PubTator, text mining | PubMed |
| The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease. | PLoS One | 2022 | 34990493 | PubTator, text mining | PubMed |
| Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. | J Med Chem | 2022 | 34982556 | PubTator, text mining | PubMed |
| Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review. | Rev Endocr Metab Disord | 2022 | 34982377 | PubTator, text mining | PubMed |
| Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections. | Chemistry | 2022 | 34981584 | PubTator, text mining | PubMed |
| A combination of Vitreoscilla filiformis extract and Vichy volcanic mineralizing water strengthens the skin defenses and skin barrier. | J Eur Acad Dermatol Venereol | 2022 | 34979591 | PubTator, text mining | PubMed |
| CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia. | Biochem Biophys Res Commun | 2022 | 34971957 | PubTator, text mining | PubMed |
| A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity. | Mol Oncol | 2022 | 34964258 | PubTator, text mining | PubMed |
| Dihydropyridine Lactam Analogs Targeting BET Bromodomains. | ChemMedChem | 2022 | 34932262 | PubTator, text mining | PubMed |
| Recurrent Urinary Tract Infections and Asymptomatic Bacteriuria in Adults. | Curr Bladder Dysfunct Rep | 2022 | 34868442 | PubTator, text mining | PubMed |
| Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab. | J Allergy Clin Immunol | 2022 | 34857395 | PubTator, text mining | PubMed |
| Noninvasive Tape-Stripping with High-Resolution RNA Profiling Effectively Captures a Preinflammatory State in Nonlesional Psoriatic Skin. | J Invest Dermatol | 2022 | 34808239 | PubTator, text mining | PubMed |
| Human intestinal bitter taste receptors regulate innate immune responses and metabolic regulators in obesity. | J Clin Invest | 2022 | 34784295 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=48